A district court ruled that the HHS does have the power to review drug manufacturers’ plans to pay hospitals rebates instead ...

Regeneron’s offer, which is still subject to court and regulatory approvals, is a bet it can do what 23andMe couldn’t and ...

Prospect Medical Holdings’ bankruptcy prompted two hospital closures in Pennsylvania. The closures caused layoffs, disrupted ...